Search

One of Japan’s greatest investors has now set his sights on India. Here are two Indian growth stocks that may have captured his attention.

With growth stocks struggling but interest rates set to rise fast, it’s a good time to add a couple defensive bank stocks to your portfolio.

Readers who took my advice to buy Tesla in 2011 are sitting on a 960% profit. If you missed out, now is another good time to buy TSLA stock.

The global middle class is expanding, and many of those consumers like to buy luxury items. And that bodes well for these 3 luxury stocks.

TSLA stock had a rough 2016. But 2017 looks much brighter for shares of the luxury electric car maker. Here are the three primary catalysts.

Energy drinks are supplanting coffee and rapidly becoming the beverage of choice for Millennials looking for a caffeine fix. These three energy drink stocks are my favorite way to take advantage of the trend.

In an address to Congress earlier this month, President Trump proposed a new “Office of Shipbuilding,” and these two stocks look like major beneficiaries.

After a D.C. court rejected the SEC’s denial of a spot Bitcoin ETF, the agency is being forced to reconsider. That could set up an arbitrage trade in Bitcoin.

Charlie Munger, a legendary investor and former vice chair of Berkshire Hathaway, recently passed away at 99. Here are a few lessons he left us with, and his final investments.

Consumer trends are changing in a big way but demand for caffeine has never been higher. That’s setting up big opportunities for investors in energy drink stocks.

You may think it’s impossible to find growth stocks trading at value prices, but you can. If you know where to look.

A rapidly evolving global threat landscape coupled with positive market sentiment has been a tailwind for this small-cap defense stock.

Arrived, a new fractional real estate investing platform, is one path to investing in real estate without breaking the bank, but it’s not the only way.

Healthcare has been one of the best-performing sectors of the last six months, and these two healthcare ETFs can help boost your portfolio in good times and bad.

Your Spring issue of Cabot’s 10 Best Marijuana Stocks is ready, with updates on the 10 stocks we’ve been following and two new stocks I’ve added to the mix.

And it’s a great time to take a fresh look at all of them, as the market’s recent correction has brought most of them down to what look like good buying areas. Yes, the correction is deep, but it was overdue, and long term, I remain very optimistic about the sector.

The major indexes have been hitting new highs in recent days, all Cabot’s market timing indicators are currently positive, and our portfolio looks good!

However, there is one sale—of a strong stock that now has less upside potential—as well as one downgrade to hold and one upgrade to buy. Details in the issue.

As to the new addition, with true growth stocks turning strong again, I’m recommending one of the strongest, a provider of hardware that enables ever-faster movement of data in the cloud-computing environment.

Details in the issue.

I’d like to start off today with two true stories. The first is about my great-grandfather, Carlton Gardner Lutts, an inventor, entrepreneur and metallurgist. Between 1929 and 1954 while working at the Boston Navy Yard, he developed and patented several improved methods of manufacturing anchor chains. That’s a diagram from one...

The market officially entered a “correction” last week when the S&P fell 10% from the 52-week high on a closing basis. Now, it’s largely up to the Fed to determine where the market goes next.

The Fed meets on Wednesday and will decide on the Fed Funds rate. They are widely expected to leave the rate unchanged and then indicate they might raise it in the future. But the main event isn’t the Fed Funds rate. It’s the benchmark 10-year Treasury yield.

The digital marketing world has been turned upside down as new privacy measures make it more challenging to track consumers across online and in-app activities.

But one company has been building out a unique opt-in data set and the backend technology to do just that. It sells this information to the biggest companies in the world so they can reach consumers with personalized marketing messages. With the new privacy measures, business is strong.

All the details are inside the May Issue of Cabot Small-Cap Confidential.